Sagetarios, Ryan S.
HRN: 23-65-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
CEFTRIAXONE 1G (VIAL)
09/05/2023
09/11/2023
IVT
1g
Q12
T/c Infected R Ankle,; S/p External Fixator R Ankle (2019)
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes